Yahoo · Nov 14, 2026
Glaukos (GKOS) Stock Fair Value Rises After Analysts Lift Targets On Strong Q3
Glaukos is back on investor radar after analysts lifted their price targets into a range of about US$225 to US$248 per share. Those higher targets are tied to what research desks describe as strong Q3 2026 execution, raised sales guidance, and traction for products like iDose and Epioxa. In the sections that follow, you will see how this evolving analyst narrative around Glaukos may shape the way you track the stock from here. Analyst Price Targets don't always capture the full story. Head...

